Kleanthis G. Xanthopoulos is Director at ANADYS PHARMACEUTICALS INC (ANDS). They have made 4 open-market trades across 2 companies since 2006, most recently 2021-06-10.
CIK 0001587221
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $35K since 2007, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZSAN | BUY | 2016-08-19 | 2016-08-22 | $1.32 | $21K | -38.2% | -38.0% | -44.8% |
| RGLS | SELL · 10b5-1 | 2015-04-17 | 2015-04-21 | $17.15 | $3.4M | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2015-03-05 | 2015-03-05 | $20.26 | $1.8M | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2015-02-27 | 2015-03-03 | $19.50 | $1K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2015-01-30 | 2015-02-03 | $19.61 | $112K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2015-01-28 | 2015-01-30 | $18.07 | $2.6M | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-29 | 2014-10-31 | $19.35 | $68K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-17 | 2014-10-21 | $7.02 | $5K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-09 | 2014-10-14 | $7.00 | $4K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-09-30 | 2014-10-02 | $7.02 | $16K | -29.3% | -0.2% | -0.2% |
| "RGLS" | SELL · 10b5-1 | 2014-08-28 | 2014-08-29 | $7.06 | $25K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-08-05 | 2014-08-07 | $7.06 | $25K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-07-01 | 2014-07-02 | $8.11 | $28K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-06-09 | 2014-06-09 | $7.14 | $25K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-05-27 | 2014-05-29 | $7.00 | $25K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-03-06 | 2014-04-09 | $7.60 | $27K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-03-06 | 2014-03-07 | $11.35 | $40K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-02-05 | 2014-02-07 | $8.40 | $29K | N/A | N/A | N/A |
| RGLS | SELL · 10b5-1 | 2014-01-02 | 2014-01-02 | $7.25 | $25K | -29.3% | -0.2% | -0.2% |
| APRI | SELL · 10b5-1 | 2013-12-26 | 2013-12-27 | $2.55 | $44K | -15.2% | -2.0% | -2.0% |
| APRI | SELL · 10b5-1 | 2013-06-21 | 2013-06-21 | $2.52 | $7K | -15.2% | -2.0% | -2.0% |
| APRI | SELL · 10b5-1 | 2013-05-21 | 2013-05-23 | $3.36 | $10K | -15.2% | -2.0% | -2.0% |
| APRI | SELL · 10b5-1 | 2013-04-22 | 2013-04-22 | $2.63 | $8K | -15.2% | -2.0% | -2.0% |
| APRI | SELL · 10b5-1 | 2013-03-21 | 2013-03-21 | $2.50 | $7K | -15.2% | -2.0% | -2.0% |
| APRI | SELL · 10b5-1 | 2012-09-28 | 2012-10-01 | $3.25 | $10K | -15.2% | -2.0% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.